News on Sodium Oxybate Therapy
In the Annals of the Rheumatic Diseases June 2012 volume 71 issue 6, we found this article about the results of an international phase 3 trial on a sodium oxybate therapy.
The conclusion of this trial is as follows: “These results, combined with findings from previous phase 2 and 3 studies, provide supportive evidence that SXB therapy affords important benefits across multiple symptoms in subjects with fibromyalgia”
The research was conducted by Michael Spaeth, Robert M. Bennet, Beverly A Benson, Y Grace Wang, Chinglin Lai, and Ernst H. Choy.
For the full article click here.